UNSPSC 51183621: Invert sugar

This classification denotes a cariogenic agents and fructose, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier ED959S6ACY. European Medicines Agency schedules Invert sugar in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14234MIG. Invert sugar generally arises in the molecular formula 2C6H12O6. The term 'invert sugar' is a U.S. FDA designation.

UNSPSC 51183621 Invert sugar is a Commodity code that, based on recent state and local solicitation activity, does not reflect the actual procurement being undertaken under this taxonomy entry. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted a Request for Proposal on January 20, 2026, for generic multi-source pharmaceuticals and over-the-counter (OTC) products — a scope entirely unrelated to invert sugar or food-ingredient procurement. The solicitation seeks manufacturers of pharmaceutical products with specific National Drug Codes (NDCs) to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) across participating state and local government facilities in Minnesota and Oregon. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain relationships with at least two of the three authorized wholesalers with chargeback systems in place, and carry comprehensive insurance including commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000.

The code shows little relevant recent activity aligned with its stated commodity scope. The single recent opportunity on record under this UNSPSC number is pharmaceutical procurement, not food ingredients or invert sugar. Proposals for the MMCAP RFP were due March 26, 2026, with the cutoff for questions on February 18, 2026, and awarded vendors to be provided to wholesalers by May 15, 2026, with contract effectiveness July 1, 2026. Evaluation weighting emphasizes price competitiveness (75 percent) alongside fixed pricing for the contract term (10 percent), EDI capability (5 percent), compliance with administrative fee data format requirements (5 percent), and agreement to a 3 percent administrative fee (5 percent). MMCAP reserves the right to make sole, dual, or multi-awards based on therapeutic considerations and member-specific needs, with contract terms of two years for new responders and extensions at MMCAP's discretion. Business development professionals should verify whether this code was mis-tagged at source or whether recent invert sugar procurement is documented elsewhere.